An infant with life-threatening hemangioma successfully treated with low-dose cyclophosphamide
Department of Pediatrics, Tsukuba University Hospital, Tsukuba, Japan.Pediatrics International (Impact Factor: 0.73). 12/2011; 53(6):1073-5. DOI: 10.1111/j.1442-200X.2011.03452.x
- [Show abstract] [Hide abstract]
ABSTRACT: Over the past decade, the treatment of infantile hemangiomas has undergone dramatic breakthroughs. This review critically evaluates the latest literature that supports the myriad treatment options for infantile hemangiomas. It chronicles the fading role of steroid therapy and evolution of propranolol use as the major treatment modality. Although propranolol is helping this disease become more of a medical disease and less of a surgical dilemma, the report also reveals a continued search to find nonsystemic treatment options. In summary, this is an evidence-based medicine review for the treatment of infantile hemangiomas. Copyright © 2015 Elsevier Inc. All rights reserved.Facial plastic surgery clinics of North America 08/2015; 23(3):373-92. DOI:10.1016/j.fsc.2015.04.009 · 0.72 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.